Members of the U.S. Senate and House of Representatives met Thursday to hash out a budget bill for a number of agencies, including the NIH, but an amendment dealing with drug prices in direct-to-consumer (DTC) ads failed to draw enough support to be reinserted into the appropriations bill. The matter is ended for now, but the concept enjoys bipartisan support on Capitol Hill and the support of the Trump administration, which has opened a docket number for drug price transparency.